drugset
drugset / Trial / NCT01211847

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

NCT01211847 ↗

Phase 2 Completed 44 enrolled Essentialis, Inc. Medpace, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Once a day oral administration with DCCR helps lower triglycerides

Timeline

Start
2010-10
Primary completion
2011-09
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazoxide Choline Unknown 290 mg Oral

Indications

hyperlipidemia hypertriglyceridemia